This short video narrated by Dr Abitbol features highlights from AWARE-CKD1 - a Canadian study assessing awareness, values, and preferences of physicians and patients with respect to CKD and T2D management.
Diabetes remains the leading contributor to the development of chronic kidney disease (CKD) and end-stage kidney disease, emphasizing the urgency of identifying barriers to early diagnosis and intervention. The primary objective of this study was to describe the awareness, values and preferences of physicians and patients with respect to managing CKD among patients with type 2 diabetes (T2D).
1. Chu L, Bhogal SK, Lin P, et al. AWAREness of Diagnosis and Treatment of Chronic Kidney Disease in Adults With Type 2 Diabetes (AWARE-CKD in T2D). Can J Diabetes. 2022; 46:464-472. Link to article